Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells. - Wikidata - awgldk - TriplyDB

Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.

Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.

http://www.wikidata.org/entity/Q33653016

about

The role of CD44 in epithelial-mesenchymal transition and cancer development CD44 Acts as a Signaling Platform Controlling Tumor Progression and Metastasis Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target Integrating intracellular dynamics using CompuCell3D and Bionetsolver: applications to multiscale modelling of cancer cell growth and invasion Fish oil prevents breast cancer cell metastasis to bone.PIK3R1 underexpression is an independent prognostic marker in breast cancer.Wnt/catenin signaling in adult stem cell physiology and disease.Copy number imbalances between screen- and symptom-detected breast cancers and impact on disease-free survival.Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells.Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loop Selection of a MCF-7 Breast Cancer Cell Subpopulation with High Sensitivity to IL-1β: Characterization of and Correlation between Morphological and Molecular Changes Leading to Increased Invasiveness.PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer.Luminal breast cancer metastasis is dependent on estrogen signaling.Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy?Wnt/beta-catenin signaling in glioma.Collective cell migration of epithelial and mesenchymal cells.Pharmacological modulation of beta-catenin and its applications in cancer therapy Molecular markers of cell adhesion in ameloblastomas. An update.Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatment.Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.FRK inhibits migration and invasion of human glioma cells by promoting N-cadherin/β-catenin complex formation.Estrogen alters the splicing of type 1 corticotropin-releasing hormone receptor in breast cancer cells.The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation.Functional heterogeneity of non-small lung adenocarcinoma cell sub-populations.Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.Dietary ω -3 polyunsaturated fatty acid DHA: a potential adjuvant in the treatment of cancer.Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma.Epsilon-aminocaproic acid prevents high glucose and insulin induced-invasiveness in MDA-MB-231 breast cancer cells, modulating the plasminogen activator system.High glucose and insulin enhance uPA expression, ROS formation and invasiveness in breast cancer-derived cells.The biology and role of CD44 in cancer progression: therapeutic implications.

P2860

Q26771509-453F7A0A-5B0C-4FC9-B612-5C9A849BFC66 Q26851466-D203D922-C77C-424B-B87D-3017D1DD25CD Q28083115-7A51B84C-509B-4A76-A3DF-91CB5EC9E82B Q29906713-15698EEE-C10D-436C-A347-C5CA2D6B82D7 Q34361670-464FB554-73FB-46A7-9CC2-E148C6024C56 Q34478129-5D0B8EE7-4737-472A-9A1A-DFB776F0B0F3 Q34959673-C43E166A-0577-4E53-8E34-D063D74A5CFD Q35281357-D69B1E3A-5082-4BF8-9072-F6F08138FA37 Q35540959-735D64BF-8641-4917-8CFB-467BF460856E Q35654152-4657E688-EDEE-46D4-B4A0-D6524A6DB5A6 Q35979001-2ECE113A-E51E-4065-AD94-6D16E40FA9AD Q36498128-89620DF9-2128-4F47-B910-DAF59031ABF8 Q36504123-05BB3E72-FF27-46F3-8341-B151680C81FE Q36545318-ABEB6DFF-7B9C-443A-952F-ABC46E8FFC1C Q37252696-204DEC08-58B2-4E36-8174-DFAFB1E67F19 Q37276323-05DA64B3-FCA3-4596-87EC-BACAD196B0BD Q37626928-F09D5C26-69F8-44A8-9FC7-ECEB3CE6B5AC Q37997724-24136C09-7561-4712-BD3B-6DC952331326 Q38073630-84CFF355-8BA9-40DB-8BFA-50367162FD82 Q38089341-FDEEE3B4-E6AF-4E2C-96F9-C68205B0699E Q38132345-328ABA3F-1F16-4530-A92E-0DF3B64D0657 Q38710557-A103890D-6A3F-419D-AB34-36132348BBB3 Q38979935-E8396016-6240-48DF-85BA-FDD5D2C30CD9 Q38980862-B52924D5-1E82-4BC2-85EE-F2D8D6DF0DCC Q39131186-64BC81D4-C639-4FD5-A1B9-EB432E9E756B Q39458532-88E81191-AAC1-45A8-BBE0-2EBA9F4B371A Q39474576-5FEBC658-326F-4B23-99C7-280A50397F97 Q39483028-2C2F70CB-1EC2-43A3-AD5B-AFCFDD434F77 Q42146247-B2D9B244-A83C-4009-911E-FADFD5E96B11 Q49830964-95B5D4A0-A9EC-4DF0-9FA2-2D4F8409BC00 Q50585983-27396A4A-396A-4107-9CD7-72A2A637C0AF Q53116632-35C02353-34AF-4B3D-B2E7-61C40D4C9241 Q54110894-8F4FFB16-3EAE-4252-B90B-E8197469C27C

P2860

Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.

http://www.wikidata.org/entity/Q33653016

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Nuclear beta-catenin and CD44 ...... ive MCF-7 breast cancer cells.

@ast

Nuclear beta-catenin and CD44 ...... ive MCF-7 breast cancer cells.

@en

type

label

Nuclear beta-catenin and CD44 ...... ive MCF-7 breast cancer cells.

@ast

Nuclear beta-catenin and CD44 ...... ive MCF-7 breast cancer cells.

@en

prefLabel

Nuclear beta-catenin and CD44 ...... ive MCF-7 breast cancer cells.

@ast

Nuclear beta-catenin and CD44 ...... ive MCF-7 breast cancer cells.

@en

P1433

Q33653016-68FC8828-7704-4876-B8AC-C0DAC71E6D68

P1476

Q33653016-4B45504F-AA61-4FC4-8E3C-8766B2546696

P2093

Q33653016-14E659C9-10DC-4A7C-AFB1-581F6F86891C

Q33653016-1FAD7168-ED08-450D-8E83-58FEDA1B77F3

Q33653016-2CB84015-A0E1-4103-ADC7-114BA1BA1DF9

Q33653016-3C2E76C6-B156-49B7-85AB-4A3EE9786063

Q33653016-3E33C9F8-7D9F-4040-8BB2-AF22747CC655

Q33653016-5CC7E380-0979-4ADD-A560-8B2F5849A2D6

Q33653016-C5B2839F-C0B9-42AC-BCD7-64C981D14379

Q33653016-FED3CFAC-93C1-407C-8323-025DB26432F4

P2860

Q33653016-01D914D1-2F63-4CF4-9549-A307477953FD

Q33653016-020A97AA-9A53-4935-B6D1-38D22CF7188F

Q33653016-118DBFF5-37A0-4240-9D69-923E825C7138

Q33653016-1257F296-D814-4CB6-A1D7-A9CD58EAA2CA

Q33653016-14D750DA-C651-4F5E-994E-7F8B0ACD81B7

Q33653016-1A14BCDE-DD15-4250-9EFD-CDC98BFC76C5

Q33653016-1C02CD86-50B6-47D3-8036-F4B47AFE992A

Q33653016-1C74ED66-C6C0-4450-8D63-047C294B81D6

Q33653016-1DFAFF38-71FA-436E-AC4A-AC14625B2907

Q33653016-1F6683B4-3034-4088-9EA1-BD409089848B

P2888

Q33653016-C845D146-088D-4A66-923A-432A86F83D36

P304

Q33653016-258FB5E1-97A4-4514-9C8F-C2904F6F3A59

P31

Q33653016-BA370A4F-8ED0-4FCF-AA87-48E40BD63781

P356

Q33653016-B879D5FC-B5B0-4879-A830-E236AA2BE778

P407

Q33653016-33B23D86-FDE7-4ABF-A1FF-B77648C77915

P478

Q33653016-315C34C4-6FE3-427A-A747-4A79EFD94E48

P577

Q33653016-325CFBEF-68B5-408C-A4A3-4CE6E189190E

P5875

Q33653016-278D8824-5BB1-4D99-8ADD-1EE9830826A5

P6179

Q33653016-2DFA0981-CE6A-44D4-8C6A-A1625D679864

P698

Q33653016-91618679-5403-4E56-A645-17C3D69DB3CC

P932

Q33653016-9518BD3E-BC2D-4008-A012-26F4B523BB4A

P356

1471-2407-10-414

P1433

P1476

Nuclear beta-catenin and CD44 ...... ive MCF-7 breast cancer cells.

@en

P2093

Fumitoshi Onoda

http://www.w3.org/2001/XMLSchema#string

Hiroko Kojima

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Satofuka

http://www.w3.org/2001/XMLSchema#string

Kenta Wada

http://www.w3.org/2001/XMLSchema#string

Masahiro Uchino

http://www.w3.org/2001/XMLSchema#string

Mika Imada

http://www.w3.org/2001/XMLSchema#string

Takahiko Utsugi

http://www.w3.org/2001/XMLSchema#string

Yasufumi Murakami

http://www.w3.org/2001/XMLSchema#string

P2860

A multidrug resistance transporter from human MCF-7 breast cancer cells

Involvement of chemokine receptors in breast cancer metastasis

Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel

CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells

The epithelial-mesenchymal transition generates cells with properties of stem cells

Prospective identification of tumorigenic breast cancer cells

The epithelial-mesenchymal transition: new insights in signaling, development, and disease

Cell migration: a physically integrated molecular process

Repeated observation of breast tumor subtypes in independent gene expression data sets

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression

P2888

1471-2407-10-414

P304

414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-10-414

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45582536

http://www.w3.org/2001/XMLSchema#string

P6179

1048627068

http://www.w3.org/2001/XMLSchema#string

P698

20696077

http://www.w3.org/2001/XMLSchema#string

P932

3087322

http://www.w3.org/2001/XMLSchema#string